AstraZeneca to discover drugs with U.K. cancer groups

AstraZeneca pledged about $6.3 million for a drug-development deal with Cancer Research Technology and the Institute of Cancer Research in the U.K. The three-year joint venture will focus on molecular chaperones, which were found to support the survival of cancer cells.

View Full Article in:

Telegraph (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA